Theralink Technologies Stock Price, News & Analysis
Company Description
Theralink Technologies (OTC Link: THER) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $615.1K.
THER stock has declined 100.0% over the past year. Shares last traded at $0.0000.
On a trailing twelve-month basis, Theralink Technologies reported revenue of $607K with net income of -$30.9M and diluted earnings per share of $-0.01. The company operates at a net profit margin of -5093.6%.
This page provides a comprehensive overview of THER stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Theralink Technologies (THER) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $615.1K, THER is classified as a micro-cap stock with approximately 6.2B shares outstanding.
Latest News
Theralink Technologies has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, earnings, management. View all THER news →
SEC Filings
Financial Highlights
Theralink Technologies generated $607K in revenue over the trailing twelve months, retaining a 79.2% gross margin, operating income reached -$9.0M (-1479.8% operating margin), and net income was -$30.9M, reflecting a -5093.6% net profit margin. Diluted earnings per share stood at $-0.01. The company generated -$5.8M in operating cash flow. With a current ratio of 0.03, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
THER Company Profile & Sector Positioning
Theralink Technologies (THER) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing THER often look at related companies in the same sector, including SYBLEU Inc (SYBE), Regen Biopharma (RGBP), Bio-Path Hldgs Inc (BPTH), Sqz Biotechnologies Co (SQZB), and Emmaus Life Scie (EMMA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate THER's relative position within its industry.